Table 1

Demographic and clinical characteristics of the participants in 9 voxel-based morphometry studies (11 data sets) included in the meta-analysis

Patients with LLDHealthy controls
StudyNo. (% female)Mean age, yr% MedicatedIllness duration, yrSeverity (scale type), stateAge at onset, yr (EO or LO)Quality scores (out of 12)ComorbidityNo. (% female)Mean age, yr
Colloby et al.1638 (71.0)74.1NA2311.6 (GDS)
12.9 (MADRS) depressed or remitted
51.8 (EO or LO)11Negative30 (66.7)74.4
Delaloye et al.27*11 (63.6)75.82731.732.36 (GDS)
11/11 remitted
74.09 (LO)11Negative30 (73.3)70.83
Delaloye et al.2730 (80.0)655029.32.47 (GDS)
30/30 remitted
35.67 (EO)11Negative30 (73.3)70.83
Egger et al.1114 (71.4)71.471.4NA21.14 (GDS)
14/14 depressed
> 60 (LO)11.5Negative20 (65)72.3
Hwang et al.2870 (0.00)79.4NA8.3429.2 (HDRS)
70/70 depressed
68.8 (LO)10Negative26 (0.00)79.5
Koolschijn et al.1528 (100)64.0478.67.7918.32 (MADRS)
8/28 depressed
33.04 (EO)12Negative38 (100)61.89
Smith et al.1216 (62.5)65.325NA26 (HDRS)
20.1 (GDS)
16/16 depressed
NA (EO or LO)11.5Negative13 (61.5)67.4
Sexton et al.1436 (66.7)71.8397.2NA4.19 (HDRS)
3.83 (GDS)
27/36 remitted
45.39 (EO or LO)10.5Some with controlled hypertension and diabetes25 (64.0)71.76
Xie et al.2918 (77.8)68.6188.9NA17.28 (GDS)
18/18 depressed
NA (EO or LO)11.5Negative25 (48.0)74.28
Xie et al.29§12 (58.3)68.3383.3NA14.25 (GDS)
12/12 depressed
NA (EO or LO)11.5MCI25 (48.0)74.28
Yuan et al.1319 (52.6)67.1Washout period > 3 mo3.73.1 (HDRS)
19/19 remitted
64.6 (LO)11.5Negative16 (50)67.7
  • EO = early onset; GDS = Geriatric Depression Scale; HDRS = Hamilton Rating Scale for Depression; LLD = late-life depression; LO = late onset; MADRS = Montgomery-Åsberg depression rating scale; MCI = mild cognitive impairment; NA = not available.

  • * Subgroup of patients with early-onset LLD.

  • Subgroup of patients with late-onset LLD.

  • Subgroup of patients with LLD without amnestic mild cognitive impairment.

  • § Subgroup of patients with LLD and comorbid amnestic mild cognitive impairment.